Grace Thayer
Nurse Practitioner · Orlando, FLNPI 1255051033
Payments from drug & device makers
Across 356 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- MDD US Operations, LLC$736
- Neurocrine Biosciences, Inc.$724
- GE HealthCare$459
- Teva Pharmaceuticals USA, Inc.$445
- Acadia Pharmaceuticals Inc$438
- plus $2K from 19 others
What the payments were for
- Food & beverage$6,271100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 76 | $1,409 |
| MDD US Operations, LLC | 50 | $736 |
| Neurocrine Biosciences, Inc. | 39 | $724 |
| GE HealthCare | 19 | $459 |
| Teva Pharmaceuticals USA, Inc. | 21 | $445 |
| Acadia Pharmaceuticals Inc | 36 | $438 |
| Eisai Inc. | 15 | $282 |
| Amneal Pharmaceuticals LLC | 15 | $275 |
| Lilly USA, LLC | 16 | $247 |
| Pfizer | 16 | $231 |
| Acorda Therapeutics, Inc | 14 | $218 |
| Tanabe Pharma America, Inc. | 8 | $165 |
| Otsuka America Pharmaceutical, Inc. | 6 | $141 |
| Kyowa Kirin, Inc. | 5 | $105 |
| Merz Pharmaceuticals, LLC | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Corium, LLC | 4 | $57 |
| UCB, Inc. | 2 | $51 |
| Boston Scientific | 1 | $30 |
| AstraZeneca | 1 | $27 |
| Impel Pharmaceuticals Inc. | 1 | $25 |
| Medtronic | 1 | $21 |
| Grifols USA, LLC | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,279 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuplazidPimavanserin Tartrate | 45 | $240,830 |
| IngrezzaValbenazine Tosylate | 19 | $155,889 |
| GocovriAmantadine Hcl | 41 | $107,915 |
| Austedo XrDeutetrabenazine | 15 | $103,998 |
| RytaryCarbidopa/Levodopa | 56 | $85,645 |
| UbrelvyUbrogepant | 33 | $43,862 |
| Nurtec OdtRimegepant Sulfate | 15 | $19,618 |
| Emgality PenGalcanezumab-Gnlm | 22 | $19,612 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 223 | $7,787 |
| Rivastigmine | 38 | $6,510 |
| Memantine Hcl | 60 | $4,231 |
| Entacapone | 14 | $2,319 |
| AmantadineAmantadine Hcl | 25 | $2,241 |
| Rasagiline Mesylate | 14 | $1,846 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 61 | $1,607 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Acadia Pharmaceuticals IncNuplazid | $438 | $240,83045 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $724 | $155,88919 claims |
| MDD US Operations, LLCGocovri | $736 | $107,91541 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $445 | $103,99815 claims |
| Amneal Pharmaceuticals LLCRytary | $275 | $85,64556 claims |
| AbbVieUbrelvy | $1,409 | $43,86233 claims |
| PfizerNurtec Odt | $231 | $19,61815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Orlando
- Jason RoyOrlando$95K
- Deborah ChandlerOrlando$60K
- Jennifer BlattnerOrlando$24K
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.